New: NCI-funded clinical trial search
Mednet Logo

Do you feel comfortable using azathioprine for dermatomyositis in patients with cirrhosis?

For example, in the setting of cirrhosis incidentally found on imaging.
2 Answers
Mednet MemberInvited Expert
Rheumatology · The University of Texas Health Science Center at Houston (UTHealth)
Answered on

Azathioprine can cause liver damage, albeit this is a rare complication and usually asymptomatic. Therefore, I would probably avoid it in cases of liver cirrhosis and try other medications, like mycophenolate, IVIG, tofactinib. In either case, I would consult at the same time with the patient's hepatologist and decide together about what kind of medication would be allowed and the kind of follow-up indicated.

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Rheumatology · Emory University
Answered on · Updated on

Great question! AZA hepatic toxicity is thought to be multifactorial but may be partially related to secondary glutathione reduction leading to mitochondrial damage. Glutathione levels are often already decreased in patients with notable hepatic dysfunction, which may theoretically increase the risk for AZA hepatic toxicity. As such, I agree with Dr. @Dr. First Last 's concerns about the risk of liver damage with AZA (even though we ironically do use it for autoimmune hepatitis).

AZA may also not be as effective in cirrhotic patients: AZA is a pro-drug which is metabolized in the liver to 6-MP and other active metabolites. Hepatic dysfunction may thus potentially decrease AZA conversion and make it less useful.

As such, I would strongly consi...

Join for free or sign in to see the full answer